STOCK TITAN

BioMarin to Participate in Three Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) announced its participation in three upcoming virtual investor conferences on November 12, 2020. Management will be presenting, and an audio webcast will be available live on their website. Archived versions of the presentations will be accessible for a limited time post-conference. BioMarin focuses on developing innovative therapies for serious rare disorders and has a strong portfolio with six commercialized products and ongoing clinical candidates. Further details can be found on their official website.

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., Nov. 12, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. 

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-upcoming-virtual-investor-conferences-301171792.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What are the dates for BioMarin's upcoming virtual investor conferences?

BioMarin announced their participation in three upcoming virtual investor conferences on November 12, 2020.

Where can I watch the live webcast for BioMarin's presentations?

The live audio webcast for BioMarin's presentations can be accessed on their investor relations website.

How can I access the archived version of BioMarin's conference presentations?

An archived version of BioMarin's conference presentations will be available on their website for a limited time after the events.

What does BioMarin Pharmaceutical focus on?

BioMarin develops and commercializes innovative therapies for serious and life-threatening rare disorders.

How many products does BioMarin have in its portfolio?

BioMarin's portfolio includes six commercialized products along with multiple clinical and pre-clinical candidates.

BioMarin Pharmaceuticals Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

12.46B
188.90M
0.87%
97.78%
2.68%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO